Cebon, Jonathan S ;
Gore, Martin ;
Thompson, John F...
Cebon , J S , Gore , M , Thompson , J F , Davis , I D , McArthur , G A , Walpole , E , Smithers , M , Cerundolo , V , Dunbar , P R , MacGregor , D , Fisher , C , Millward , M , Nathan , P , Findlay , M P N , Hersey , P , Evans , T R J , Ottensmeier , C H , Marsden , J , Dalgleish , A G , Corrie , P G , Maria , M , Brimble , M , Williams , G , Winkler , S , Jackson , H M , Endo-Munoz , L , Tutuka , C S A , Venhaus , R , Old , L J , Haack , D , Maraskovsky , E , Behren , A & Chen , W 2020 , ' Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma ' , Journal for ImmunoTherapy of Cancer , vol. 8 , no. 1 , e000410 . https://doi.org/10.1136/jitc-2019-000410.
,
2020
